Rhinocort


Also found in: Dictionary.

Rhinocort

(rī′nə-kôrt′)
A trademark for the drug budesonide.

Rhinocort

a trademark for a nasal corticosteroid (budesonide).

budesonide

A nebulisable synthetic glucocorticosteroid, structurally related to 16α-hydroxyprednisolone, which has high topical anti-inflammatory activity, low systemic activity and enhanced receptor-binding activity, but more rapid presystemic metabolism than other corticosteroids.

Indications
Coup, asthma, allergic rhinitis, inflammatory colitides—e.g., ulcerative colititis and Crohn’s disease; seasonal or perennial.
 
Adverse effects
Nasal irritation, sores and bleeding, upset stomach, cough, dry mouth, rash, muscle cramps.
Mentioned in ?
References in periodicals archive ?
Rhinocort Aqua is a nasal spray indicated for allergic and non-allergic rhinitis (inflammation of the inside of the nose), and for the treatment of nasal polyps (swelling of the nasal lining).
AstraZeneca, an English-Swedish multinational pharmaceutical and biopharmaceutical company, has agreed to sell rights outside the United States for Rhinocort Aqua nasal spray to Cilag GmbH International, an affiliate of Johnson & Johnson.
Recently Rhinocort Aqua, a nasal steroid spray, was approved for children six years of age and older.
The companies have signed an agreement giving Pfizer a right of first refusal regarding OTC rights for Rhinocort Aqua, a pump spray containing the glucocorticosteroid budesonide, with a local anti-inflammatory effect, for the treatment of non-infectious rhinitis (such as hay fever and house dust mite allergy).
The most recent switched products include Flonase Sensimist Allergy Relief from GSK Consumer Health Care, and Rhinocort Allergy Spray from the McNeil Consumer Products division of Johnson & Johnson.
M2 EQUITYBITES-October 10, 2016-AstraZeneca to sell certain rights for Rhinocort Aqua nasal spray to Cilag International
is set to launch AstraZeneca's Rhinocort in the next year.
The companies have signed a right of first refusal regarding OTC rights for Rhinocort Aqua, a pump spray containing the glucocorticosteroid budesonide, with a local anti-inflammatory effect for the treatment of non-infectious rhinitis (such as hay fever and house dust mite allergy).
Murphy, reporting the findings from the study that was funded by AstraZeneca, makers of Rhinocort Aqua.
But prescription nasal sprays, or topical steroids such as Vancenase, Flonase, Rhinocort or Nasacort, work very well for allergy sufferers without fear of dependency.
The decline during the forecast period can be attributed to the expected patent expiry of Astelin (azelastine hydrochloride), Nasonex (mometasone furoate), Nasacort AQ (triamcinolone acetonide) and Rhinocort Aqua (budesonide) in the year 2011, 2014, 2016 (US) and 2017 respectively.